Plasma amyloid beta X-42/X-40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease

Jonathan Vogelgsang*, Niels Hansen, Melina Stark, Michael Wagner, Hans Klafki, Barbara Marcos Morgado, Anke Jahn-Brodmann, Björn Schott, Hermann Esselmann, Chris Bauer, Johannes Schuchhardt, Luca Kleineidam, Steffen Wolfsgruber, Oliver Peters, Luisa-Sophie Schneider, Xiao Wang, Felix Menne, Josef Priller, Eike Spruth, Slawek AltensteinAndrea Lohse, Anja Schneider, Klaus Fliessbach, Ina Vogt, Claudia Bartels, Frank Jessen, Ayda Rostamzadeh, Emrah Duezel, Wenzel Glanz, Enise Incesoy, Michaela Butryn, Katharina Buerger, Daniel Janowitz, Michael Ewers, Robert Perneczky, Boris Rauchmann, Selim Guersel, Stefan Teipel, Ingo Kilimann, Doreen Goerss, Christoph Laske, Matthias Munk, Carolin Sanzenbacher, Annika Spottke, Nina Roy-Kluth, Michael Heneka, Frederic Brosseron, Alfredo Ramierez, Matthias Schmid, Jens Wiltfang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Plasma amyloid beta X-42/X-40 ratio and cognitive decline in suspected early and preclinical Alzheimer's disease'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Material Science